Effect of nabumetone on metabolism of renal arachidonate in humans. 1992

R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
CNR Institute of Clinical Physiology, Pisa, Italy.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009280 Naphthaleneacetic Acids Naphthalene derivatives containing the -CH2CCO2H radical at the 1-position, the 2-position, or both. Compounds are used as plant growth regulators to delay sprouting, exert weed control, thin fruit, etc. Acids, Naphthaleneacetic
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D002074 Butanones Derivatives of butanone, also known as methyl ethyl ketone (with structural formula CH3COC2H5).
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077430 Nabumetone A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS. 4-(6-Methoxy-2-naphthyl)-2-butanone,Apo-Nabumetone,Arthraxan,BRL 14777,Gen-Nabumetone,Listran,Mebutan,Nabucox,Nabumeton,Relafen,Relif,Relifex,Rhoxal-nabumetone,ApoNabumetone,Rhoxal nabumetone

Related Publications

R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
September 1995, Clinical pharmacology and therapeutics,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
September 1989, Prostaglandins, leukotrienes, and essential fatty acids,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
October 1991, Biological chemistry Hoppe-Seyler,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
March 1990, Revista espanola de fisiologia,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
January 1986, Advances in prostaglandin, thromboxane, and leukotriene research,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
January 1981, Progress in lipid research,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
January 1978, Farmakologiia i toksikologiia,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
October 1985, Biochemical pharmacology,
R De Caterina, and D Giannessi, and G Lazzerini, and P Filipponi, and C Mannarelli, and G Vaiani, and E Grossi
July 1989, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!